Cargando…

Cryo-EM structure determination of small therapeutic protein targets at 3 Å-resolution using a rigid imaging scaffold

Cryoelectron microscopy (Cryo-EM) has enabled structural determination of proteins larger than about 50 kDa, including many intractable by any other method, but it has largely failed for smaller proteins. Here, we obtain structures of small proteins by binding them to a rigid molecular scaffold base...

Descripción completa

Detalles Bibliográficos
Autores principales: Castells-Graells, Roger, Meador, Kyle, Arbing, Mark A., Sawaya, Michael R., Gee, Morgan, Cascio, Duilio, Gleave, Emma, Debreczeni, Judit É., Breed, Jason, Leopold, Karoline, Patel, Ankoor, Jahagirdar, Dushyant, Lyons, Bronwyn, Subramaniam, Sriram, Phillips, Chris, Yeates, Todd O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500258/
https://www.ncbi.nlm.nih.gov/pubmed/37669364
http://dx.doi.org/10.1073/pnas.2305494120
Descripción
Sumario:Cryoelectron microscopy (Cryo-EM) has enabled structural determination of proteins larger than about 50 kDa, including many intractable by any other method, but it has largely failed for smaller proteins. Here, we obtain structures of small proteins by binding them to a rigid molecular scaffold based on a designed protein cage, revealing atomic details at resolutions reaching 2.9 Å. We apply this system to the key cancer signaling protein KRAS (19 kDa in size), obtaining four structures of oncogenic mutational variants by cryo-EM. Importantly, a structure for the key G12C mutant bound to an inhibitor drug (AMG510) reveals significant conformational differences compared to prior data in the crystalline state. The findings highlight the promise of cryo-EM scaffolds for advancing the design of drug molecules against small therapeutic protein targets in cancer and other human diseases.